Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Schubiger

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Schweizerische Medizinische Wochenschrift|October 31, 1992
[New receptor ligands for single-photon emission tomography of the brain]P A Schubiger
Ernst Schering Research Foundation Workshop|December 19, 2006
Molecular imaging with PET--open questions?P A Schubiger
Pharmaceutica Acta Helvetiae|September 1, 1995
Optimising the radioimmunotherapy of malignant disease: the broadening choice of carrier and effector moietiesP A Schubiger, A Smith
Nuklearmedizin. Nuclear Medicine|October 1, 1986
Radiolabelling of antibodies: methods and limitationsR Y Andres, P A Schubiger
European Journal of Nuclear Medicine and Molecular Imaging|May 2, 2003
Sensitivity or resolution - or both? "State of the Art Imaging Using Small Animal PET Scanners" report on the 10th Böttstein Colloquium/2nd Workshop on Basic Research in Molecular Imaging, 11-12 October 2002, Villigen, SwitzerlandM Schäfers, S Ametamey, P A Schubiger
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 1, 1997
Reinvestigation of a physiological eluate of the 52Fe/52mMn generatorP Bläuenstein, R Pellikka, P A Schubiger
Bioconjugate Chemistry|March 1, 1996
Vehicles, chelators, and radionuclides: choosing the "building blocks" of an effective therapeutic radioimmunoconjugateP A Schubiger, R Alberto, A Smith
Cancer Research|December 1, 1990
Regulation of the cell surface expression of a nonspecific cross-reacting antigen variant during differentiation of HL-60 cellsI Novak-Hofer, P Bläuenstein, P A Schubiger
Cancer Biotherapy & Radiopharmaceuticals|January 16, 2002
Peptide linkers lead to modification of liver metabolism and improved tumor targeting of copper-67-labeled antibody fragmentsI Novak-Hofer, K Zimmermann, P A Schubiger
Nuklearmedizin. Nuclear Medicine|February 1, 1984
Mixed micells: a new problem-free solution for omega-123I-heptadecanoic acid in comparisonP A Schubiger, M Argentini, P Bläuenstein, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Schweizerische Medizinische Wochenschrift|October 31, 1992
[New receptor ligands for single-photon emission tomography of the brain]P A Schubiger
Ernst Schering Research Foundation Workshop|December 19, 2006
Molecular imaging with PET--open questions?P A Schubiger
Pharmaceutica Acta Helvetiae|September 1, 1995
Optimising the radioimmunotherapy of malignant disease: the broadening choice of carrier and effector moietiesP A Schubiger, A Smith
Nuklearmedizin. Nuclear Medicine|October 1, 1986
Radiolabelling of antibodies: methods and limitationsR Y Andres, P A Schubiger
European Journal of Nuclear Medicine and Molecular Imaging|May 2, 2003
Sensitivity or resolution - or both? "State of the Art Imaging Using Small Animal PET Scanners" report on the 10th Böttstein Colloquium/2nd Workshop on Basic Research in Molecular Imaging, 11-12 October 2002, Villigen, SwitzerlandM Schäfers, S Ametamey, P A Schubiger
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 1, 1997
Reinvestigation of a physiological eluate of the 52Fe/52mMn generatorP Bläuenstein, R Pellikka, P A Schubiger
Bioconjugate Chemistry|March 1, 1996
Vehicles, chelators, and radionuclides: choosing the "building blocks" of an effective therapeutic radioimmunoconjugateP A Schubiger, R Alberto, A Smith
Cancer Research|December 1, 1990
Regulation of the cell surface expression of a nonspecific cross-reacting antigen variant during differentiation of HL-60 cellsI Novak-Hofer, P Bläuenstein, P A Schubiger
Cancer Biotherapy & Radiopharmaceuticals|January 16, 2002
Peptide linkers lead to modification of liver metabolism and improved tumor targeting of copper-67-labeled antibody fragmentsI Novak-Hofer, K Zimmermann, P A Schubiger
Nuklearmedizin. Nuclear Medicine|February 1, 1984
Mixed micells: a new problem-free solution for omega-123I-heptadecanoic acid in comparisonP A Schubiger, M Argentini, P Bläuenstein, et al.
Pageof 9